$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
乐伐替尼治疗分化型甲状腺癌的临床数据
2025-10-19 11:44:20
Check Details
乐伐替尼延长分化型甲状腺癌患者的生存期
2025-10-19 11:44:20
Check Details
卡博替尼在肝细胞癌中的应用:2期安慰剂对照研究结果
2025-10-19 11:44:20
Check Details
仑伐替尼治疗甲状腺癌
2025-10-19 11:44:20
Check Details
乐伐替尼治疗甲状腺癌有效率
2025-10-19 11:44:20
Check Details
乐伐替尼治疗放射性碘治疗失败分化型甲状腺癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗甲状腺髓样癌
2025-10-19 11:44:20
Check Details
卡博替尼治疗甲状腺髓样癌的效果
2025-10-19 11:44:20
Check Details
卡博替尼治疗甲状腺髓样癌的推荐剂量
2025-10-19 11:44:20
Check Details
乐伐替尼治疗甲状腺癌无进展生存期显著延长
2025-10-19 11:44:20
Check Details
卡博替尼延长甲状腺随样癌无进展生存期
2025-10-19 11:44:20
Check Details
甲状腺癌患者服用索拉非尼的治疗效果怎么样?
2025-10-19 11:44:20
Check Details
1
2
...
2445
2446
2447
2448
2449
2450
2451
...
4161
4162
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
2
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
3
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
4
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
5
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
6
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
7
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
8
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
9
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile
10
Abemaciclib for HR+ HER2- Breast Cancer: Mechanism, Combination Therapy, and Switching Considerations
11
Cemiplimab Mechanism of Action: How PD-1 Inhibition Restores Antitumor Immunity
12
Tivozanib Dosing Guide for Renal Cell Carcinoma: 21-Day On/7-Day Off Cycle and Adjustments